IL6 and thrombocytosis disease: The clinical manifestations of MCD are largely driven by activation of the interleukin-6 (IL6) signaling cascade, which results in an acute phase reaction with elevated erythrocyte sedimentation rate, C-reactive protein (CRP), fibrinogen, thrombocytosis and hypergammaglobulinemia [2], [4], [5].